Nipro ES Pharma

Nipro ES Pharma is a Japanese pharmaceutical company that specializes in the manufacturing and sale of generic drugs and long-listed original products. Originally established as Tanabe Seiyaku Hanbai, the company became a subsidiary of Nipro Corporation in 2017 and was subsequently renamed to reflect its integration into the Nipro Group. The company focuses on providing a stable supply of high-quality, value-added generic medicines across various therapeutic areas, including cardiovascular, metabolic, and infectious diseases. By leveraging Nipro's extensive medical device and manufacturing expertise, Nipro ES Pharma aims to improve patient adherence through innovative drug delivery systems and packaging. The company plays a critical role in the Japanese healthcare system by supporting cost-containment efforts through its robust portfolio of essential medicines.